NUVL

Nuvalent, Inc.

78.84 USD
+0.19 (+0.24%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Nuvalent, Inc. stock is down -0.18% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 3 July’s closed higher than June. In the last 5 Unusual Options Trades, there were 2 PUTs, 3 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
31 May 13:50 21 Jun, 2024 60.00 PUT 250 2
06 Jun 17:58 20 Dec, 2024 95.00 CALL 83 0
07 Jun 17:44 19 Jul, 2024 80.00 CALL 50 52
20 Jun 14:45 16 Aug, 2024 85.00 CALL 316 0
26 Jun 14:39 17 Jan, 2025 45.00 PUT 150 10

About Nuvalent, Inc.

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations.